Page last updated: 2024-08-17

medroxyprogesterone acetate and Elevated Cholesterol

medroxyprogesterone acetate has been researched along with Elevated Cholesterol in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (45.45)18.2507
2000's6 (54.55)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berenson, AB; Rahman, M; Wilkinson, G1
Chayama, K; Higashi, Y; Kimura, M; Kodama, I; Nakagawa, K; Ohama, K; Sanada, M; Tsuda, M1
Kremastinos, DT; Kyriakides, ZS; Sbarouni, E1
Latrilha, MC; Maranhão, RC; Melo, NR; Pompei, LM; Santos, RD1
Koval, JJ; Nisker, JA; Wolfe, BM1
Birkenhäger, JC; Deckers, JW; Hoogerbrugge, N; Jansen, H; Meeter, K; Zillikens, MC1
Kyriakides, ZS; Sbarouni, E1
Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E1
Kodama, I; Nakagawa, H; Ohama, K; Sakashita, T; Sanada, M; Tsuda, M1
Akerblom, M; Li, C; Samsioe, G1
Darling, GM; Davis, SR; Johns, JA; McCloud, PI1

Trials

7 trial(s) available for medroxyprogesterone acetate and Elevated Cholesterol

ArticleYear
Effect of simvastatin on serum C-reactive protein during hormone replacement therapy.
    The American journal of cardiology, 2004, Jan-15, Volume: 93, Issue:2

    Topics: Aged; C-Reactive Protein; Coronary Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Medroxyprogesterone Acetate; Postmenopause; Simvastatin; Time Factors

2004
Effects in post-menopausal women of transdermal estrogen associated with progestin upon the removal from the plasma of a microemulsion that resembles low-density lipoprotein (LDL).
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Cholesterol Esters; Cholesterol, LDL; Emulsions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Treatment Outcome

2005
Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
    American journal of obstetrics and gynecology, 1998, Volume: 178, Issue:4

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cross-Over Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Norgestrel; Postmenopause; Prospective Studies; Triglycerides

1998
The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:5

    Topics: Aged; Anticholesteremic Agents; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Simvastatin; Treatment Outcome

1998
Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease.
    European heart journal, 2000, Volume: 21, Issue:12

    Topics: Aged; Anticholesteremic Agents; Cell Adhesion Molecules; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Male; Medroxyprogesterone Acetate; Middle Aged; Simvastatin

2000
Electrocardiogram pattern in hypercholesterolemic women: the influence of hormone replacement therapy.
    Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:4

    Topics: Aged; Cardiovascular Diseases; Cohort Studies; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Premenopause

1998
Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 1999, Volume: 2, Issue:3

    Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Humans; Hypercholesterolemia; Lipoprotein(a); Medroxyprogesterone Acetate; Postmenopause; Simvastatin; Treatment Outcome; Triglycerides

1999

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and Elevated Cholesterol

ArticleYear
Effect of injectable and oral contraceptives on serum lipids.
    Obstetrics and gynecology, 2009, Volume: 114, Issue:4

    Topics: Adolescent; Adult; Black or African American; Cholesterol; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Hypercholesterolemia; Hypertriglyceridemia; Longitudinal Studies; Medroxyprogesterone Acetate; Triglycerides; White People; Young Adult

2009
Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10

    Topics: Arteries; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Hypercholesterolemia; Hyperemia; Lipids; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Nitroglycerin; Peptidyl-Dipeptidase A; Plethysmography; Postmenopause; Vascular Resistance

2002
Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease.
    Metabolism: clinical and experimental, 1998, Volume: 47, Issue:6

    Topics: Autoantibodies; Cholesterol, HDL; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Lipoprotein Lipase; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Particle Size; Postmenopause; Smoking

1998
Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy.
    Maturitas, 2001, May-30, Volume: 38, Issue:3

    Topics: Adult; Aged; Apolipoproteins E; Asian People; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Japan; Medroxyprogesterone Acetate; Middle Aged; Phenotype; Postmenopause; Prospective Studies

2001